Alzheimer’s disease (AD) is characterized by cognitive decline and loss of neurons in specific brain regions. Recent findings have suggested an involvement of brain-derived neurotrophic factor (BDNF) in the pathogenesis of AD. BDNF is an endogenous protein involved in the maintenance of neuronal function, synaptic plasticity and structural integrity in the adult brain.
To our knowledge, the present pilot study assessed for the first time BDNF serum and CSF concentrations in 30 patients with different stages of AD in comparison to 10 age-matched non-demendet controls. AD patients were divided in two groups according to their MMSE score: Group 1 (n = 15) in early stages with MMSE scores ≥21 (mean of 25.5) and Group 2 (n = 15) with more severe stages of dementia with MMSE scores <21 (mean of 13.3).
As main results, we found in patients with early stages of probable AD significantly increased BDNF serum concentrations as compared to more severe stages of AD (p < 0.0001) and age-matched healthy controls (p = 0.028). BDNF serum values in all AD patients correlated significantly with MMSE scores (r = 0.486; p < 0.0001). Levels of BDNF were below the detection limit of the assay in unconcentrated CSF samples of AD patients and non-demendet controls.
In summary, BDNF serum values are increased in early stages of Alzheimer’s disease, which may reflect a compensatory repair mechanism in early neurodegeneration and could also contribute to increased degradation of beta-amyloid (Abeta). During the course of the disease, BDNF is decreasing, which correlates with the severity of dementia. The decrease of BDNF may constitute a lack of trophic support with an increase of Abeta accumulation and thus contribute to progressive degeneration of specific regions in the AD-affected brain. BDNF should be further evaluated as a candidate marker for clinical diagnosis and therapeutic monitoring in Alzheimer’s disease.
Keywords: Alzheimer’s disease (AD), early stages, late stages, BDNF, serum, CSF, healthy controls, MMSE.
Blasko, I, Grubeck-Loebenstein, B 2003Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer’s diseaseDrugs Aging20101113PubMedCrossRefGoogle Scholar
Brion, JP, Anderton, BH, Authelet, M, Dayanandan, R, Leroy, K, Lovestone, S, Octave, JN, Pradier, L, Touchet, N, Tremp, G 2001Neurofibrillary tangles and tau phosphorylationBiochem Soc Symp678188PubMedGoogle Scholar
Burbach, GJ, Hellweg, R, Haas, CA, Del Turco, D, Deicke, U, Abramowski, D, Jucker, M, Staufenbiel, M, Deller, T 2004Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic miceJ Neurosci2424212430PubMedCrossRefGoogle Scholar
Connor, B, Young, D, Lawlor, P, Gai, W, Waldvogel, H, Faull, RL, Dragunow, M 1996Trk receptor alterations in Alzheimer’s diseaseBrain Res Mol Brain Res42117PubMedCrossRefGoogle Scholar
APA1994Diagnostic and statistical manual of mental disorders4DSM-4. American Psychiatric AssociationWashington, DCGoogle Scholar
Durany, N, Michel, T, Kurt, J, Cruz-Sanchez, FF, Cervas-Navarro, J, Riederer, P 2000Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer’s disease brainsInt J Dev Neurosci18807813CrossRefGoogle Scholar
Folstein, MF, Folstein, SE, McHugh, PR 1975“Mini-Mental-State”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res12189198PubMedCrossRefGoogle Scholar
Foulstone, EJ, Tavare, JM, Gunn-Moore, FJ 1999Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cellsNeurosci Lett264125128PubMedCrossRefGoogle Scholar
Fujimura, H, Altar, CA, Chen, R, Nakamura, T, Nakahashi, T, Kambayashi, J, Sun, B, Tandon, NN 2002Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulationThromb Haemost87728734PubMedGoogle Scholar
Hock, C, Heese, K, Hulette, C, Rosenberg, C, Otten, U 2000Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areasArch Neurol57846851PubMedCrossRefGoogle Scholar
Holsinger, RM, Schnarr, J, Henry, P, Castelo, VT, Fahnestock, M 2000Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer’s diseaseBrain Res Mol Brain Res76347354PubMedCrossRefGoogle Scholar
Karege, F, Schwald, M, Cisse, M 2002Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and plateletsNeurosci Lett328261264PubMedCrossRefGoogle Scholar
Kerschensteiner, M, Gallmeier, E, Behrens, L, Leal, VV, Misgeld, T, Klinkert, WE, Kolbeck, R, Hoppe, E, Oropeza-Wekerle, RL, Bartke, I, Stadelmann, C, Lassmann, H, Wekerle, H, Hohlfeld, R 1999Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammationJ Exp Med189865870PubMedCrossRefGoogle Scholar
Kircher, T, Wormstall, H 1997Alois Alzheimer (1864–1915) – student days and first scientific activitiesJ Geriatr Psychiatry Neurol10127129PubMedGoogle Scholar
Laske, C, Stransky, E, Eschweiler, G, Wittorf, A, Richartz-Salzburger, E, Bartels, M, Buchkremer, G, Schott, K 2005aBDNF serum concentrations in patients with Alzheimer’s disease are associated with depressive mood statesNeurol Psychiatr Brain Res1214Google Scholar
Laske, C, Stransky, E, Eschweiler, GW, Wittorf, A, Richartz-Salzburger, E, Buchkremer, G, Schott, K 2005bCorrelation of BDNF and IL-6 serum concentrations in Alzheimer’s diseaseNeurol Psychiatr Brain Res122124Google Scholar
Laske, C, Morawetz, C, Buchkremer, G, Wormstall, H 2005cPrevention of dementiaDtsch Ärztebl102A14461453Google Scholar
Laske C, Eschweiler GW (2006) Brain-derived neurotrophic factor (BDNF): from nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases. Nervenarzt (in press)Google Scholar
Lindvall, O, Ernfors, P, Bengzon, J, Kokaia, Z, Smith, ML, Siesjo, BK, Persson, H 1992Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic comaProc Natl Acad Sci USA89648652PubMedCrossRefGoogle Scholar
Marmigere, F, Choby, C, Rage, F, Richard, S, Tapia-Arancibia, L 2001Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell culturesNeuroendocrinology744354PubMedCrossRefGoogle Scholar
Mattson, MP, Maudsley, S, Martin, B 2004BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disordersTrends Neurosci27589594PubMedCrossRefGoogle Scholar
Mc Khann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM 1984Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology343044Google Scholar
Meda, L, Cassatella, MA, Szendrei, GI, Otvos, L, Baron, P, Villalba, M, Ferrari, D, Rossi, F 1995Activation of microglial cells by beta-amyloid protein and interferon-gammaNature374647651PubMedCrossRefGoogle Scholar
Michalski, B, Fahnestock, M 2003Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s diseaseBrain Res Mol Brain Res111148154PubMedCrossRefGoogle Scholar
Pan, W, Banks, WA, Fasold, MB, Bluth, J, Kastin, AJ 1998Transport of brain-derived neurotrophic factor across the blood-brain barrierNeuropharmacology3715531561PubMedCrossRefGoogle Scholar
Phillips, HS, Hains, JM, Armanini, M, Laramee, GR, Johnson, SA, Winslow, JW 1991BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s diseaseNeuron7695702PubMedCrossRefGoogle Scholar
Poduslo, JF, Curran, GL 1996Permeability at the blood-brain barrier and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNFMol Brain Res36280286PubMedCrossRefGoogle Scholar
Saito, T, Iwata, N, Tsubuki, S, Takaki, Y, Takano, J, Huang, SM, Suemoto, T, Higuchi, M, Saido, TC 2005Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradationNat Med11434439PubMedCrossRefGoogle Scholar
Tang, Y, Yamada, K, Kanou, Y, Miyazaki, T, Xiong, X, Kambe, F, Murata, Y, Seo, H, Nabeshima, T 2000Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of beta-amyloid in ratsBrain Res Mol Brain80188197CrossRefGoogle Scholar
Villuendas, G, Sanchez-Franco, F, Palacios, N, Fernandez, M, Cacicedo, L 2001Involvement of VIP on BDNF-induced somatostatin gene expression in cultured fetal rat cerebral cortical cellsBrain Res Mol Brain Res945966PubMedCrossRefGoogle Scholar
World Health Organization (WHO) (1988) Tenth revision of the International Classification of Diseases, chapter 5 (F). Mental and behavioural disorders (including disorders of psychological development). Clinical descriptions and diagnostic guidelines. WHO, GenevaGoogle Scholar
Yasutake, C, Yanagawa, T, Okamura, T, Yoneda, H 2005Serum BDNF, TNF-alpha, IL-1beta levels in dementia patientsWorld J Biol Psychiatry6215Google Scholar